What is a stock summary page? Click here for an overview.
Business Description
Atreca Inc
NAICS : 325412
SIC : 2834
ISIN : US04965G1094
Share Class Description:
BCEL: Class ACompare
Compare
Traded in other countries / regions
BCEL.USA0C1.Germany Index Membership
Russell 2000 IPO Date
2019-06-20Description
Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. It has single segment business of therapeutic drug discovery and development. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform.
Financial Strength
Name | Current | Vs Industry | Vs History |
---|
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 48.16 | |||||
9-Day RSI | 49.41 | |||||
14-Day RSI | 50.56 | |||||
6-1 Month Momentum % | -61.22 | |||||
12-1 Month Momentum % | -91.36 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
Name | Current | Vs Industry | Vs History |
---|
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-Forward-EBIT | -0.44 | |||||
EV-to-Forward-EBITDA | -0.44 | |||||
EV-to-Forward-Revenue | 9.7 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BCEL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Atreca Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -2.5 | ||
Beta | - | ||
3-Year Sharpe Ratio | -0.53 | ||
3-Year Sortino Ratio | -0.87 | ||
Volatility % | 168.69 | ||
14-Day RSI | 50.56 | ||
14-Day ATR ($) | 0.009986 | ||
20-Day SMA ($) | 0.09068 | ||
12-1 Month Momentum % | -91.36 | ||
52-Week Range ($) | 0.052 - 1.2 | ||
Shares Outstanding (Mil) | 39.65 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 0 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Atreca Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Atreca Inc Stock Events
Event | Date | Price ($) | ||
---|---|---|---|---|
No Event Data |
Atreca Inc Frequently Asked Questions
What is Atreca Inc(BCEL)'s stock price today?
The current price of BCEL is $0.09. The 52 week high of BCEL is $1.20 and 52 week low is $0.05.
When is next earnings date of Atreca Inc(BCEL)?
The next earnings date of Atreca Inc(BCEL) is 2025-06-27 Est..
Does Atreca Inc(BCEL) pay dividends? If so, how much?
Atreca Inc(BCEL) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |